Teknova
Matthew Lowell has served as our Chief Financial Officer since February 2021. Prior to joining Teknova, he served as Vice President of Finance and Treasurer at Varex Imaging Corporation (NASDAQ: VREX), a medical device company, while also leading business development activity. Matt also served as Vice President of Finance at Varian Medical Systems, Inc. (“Varian”) (NYSE: VAR) from April 2013 to December 2016, prior to the spin-off of Varex Imaging Corporation from Varian in January 2017, with responsibility for financial planning and analysis as well as business development. Before joining Varian, he spent over 10 years, from 2002 to 2013, at Abbott Medical Optics, Inc. and its predecessor, Advanced Medical Optics, Inc. in a variety of strategy, business development, and finance roles.
Matt began his career in investment banking with positions at NationsBank, N.A. in its Investment Banking division, at Donaldson, Lufkin & Jenrette, Inc., and at Credit Suisse First Boston. He holds a bachelor’s degree in Economics from the University of North Carolina at Chapel Hill and a master’s degree in Business Administration from the Kellogg School of Management at Northwestern University.
This person is not in any offices
Teknova
Teknova expedites clinical breakthroughs by allowing scientists to focus on discovery, product development, and production. An established leader in custom manufacturing for the life science, biopharma, and healthcare industries, Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents.